Traws Pharma, Inc.
TRAW
$1.86
$0.2012.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 171.82% | -253.06% | 93.12% | -2,371.26% | -19.10% |
| Total Depreciation and Amortization | -50.00% | 0.00% | -50.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -206.38% | 7,122.16% | -99.71% | 35,288.59% | 0.30% |
| Change in Net Operating Assets | -151.99% | 133.11% | 26.57% | -2,152.70% | 138.14% |
| Cash from Operations | -34.58% | 64.80% | -16.48% | -122.69% | 0.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.32% | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.93% | -- | -100.00% | -- | -- |
| Foreign Exchange rate Adjustments | 355.56% | -- | 100.00% | 57.14% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.91% | 238.79% | -2,413.71% | 111.19% | -0.18% |